AMDA - The Society for Post-Acute and Long-Term Care Medicine Revenue and Competitors

Columbia, MD USA

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • AMDA - The Society for Post-Acute and Long-Term Care Medicine's estimated annual revenue is currently $7.5M per year.(i)
  • AMDA - The Society for Post-Acute and Long-Term Care Medicine's estimated revenue per employee is $78,125

Employee Data

  • AMDA - The Society for Post-Acute and Long-Term Care Medicine has 96 Employees.(i)
  • AMDA - The Society for Post-Acute and Long-Term Care Medicine grew their employee count by 33% last year.

AMDA - The Society for Post-Acute and Long-Term Care Medicine's People

NameTitleEmail/Phone
1
Director Public Policy and AdvocacyReveal Email/Phone
2
Director, Clinical AffairsReveal Email/Phone
3
Senior Director, Advocacy and Strategic PartnershipsReveal Email/Phone
4
Industry Relations ManagerReveal Email/Phone
5
Accreditation ManagerReveal Email/Phone
6
Member Relations & Marketing SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15M21511%N/AN/A
#2
$35M740%N/AN/A
#3
$4.1M29-9%N/AN/A
#4
$7.5M797%N/AN/A
#5
$9.7M6911%N/AN/A
#6
$0.6M4-20%N/AN/A
#7
$3.5M4348%N/AN/A
#8
$15M25816%N/AN/A
#9
$15M10327%N/AN/A
#10
$7.5M6722%N/AN/A
Add Company

What Is AMDA - The Society for Post-Acute and Long-Term Care Medicine?

AMDA - The Society for Post-Acute and Long-Term Care Medicine is dedicated to excellence in patient care and provides education, advocacy, information and professional development to promote the delivery of quality post-acute and long-term care medicine. Vision: A world in which all post-acute and long-term care patients and residents receive the highest- quality, compassionate care for optimum health, function, and quality of life.

keywords:N/A

N/A

Total Funding

96

Number of Employees

$7.5M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.1M962%N/A
#2
$13.9M96-14%N/A
#3
$13.4M9622%N/A
#4
$33.6M9717%N/A
#5
$13.6M9764%N/A